Government brings modern medical products under CLAA oversight
Delhi, July 2 – The central government revised the Drugs Rules to place cell‑derived biologics, gene‑therapy agents and xenograft materials under the Central Licensing Authority. Officials say the amendment will streamline licensing, foster innovation and protect patients as these high‑risk therapies become more common.